KORU Medical Systems, Inc. (KRMD) stock
Close on Nov 11, 2026Market cap $179.61MP/E –Yield –
KORU Medical Systems, Inc. grew revenue 18.4% to $46.27M over the twelve months to Sep 30, 2026. Free cash flow was -$387.37K. At the latest close the market valued the company at $179.61M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $179.61M
- P/E ratio
- –
- Price to sales
- 3.88
- Price to book
- 9.26
- Dividend yield
- –
- Free cash flow yield
- -0.22%
Fundamentals
- Revenue
- $46.27M
- Net income
- -$823.38K
- EPS, diluted
- -$0.02
- Free cash flow
- -$387.37K
- Book value per share
- $0.42
- Diluted shares
- 47M
Trading
- Next earnings
- Mar 11, 2027 (estimated, after the close)
- Previous close
- $3.16
- Open
- $3.32
- Day's range
- $3.30 – $3.96
- Volume
- 727,273
- Average volume (20 days)
- 172,928
- Index membership
- Russell 2000 (since Jun 2025)
- Beta (5 years)
- 0.99
- 52-week range
- $2.86 – $6.61
- RSI (14 days)
- 71.5
- Volatility (1 year)
- 54.9%
- Relative volume
- 3.43×
- WACC
- 9.8%
On 1 of our idea list: Insiders buying the dip
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | KRMD | S&P 500 | Difference | KRMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +31.4% | -2.4% | +33.8 pts | ||
| 3 months | +12.8% | -1.2% | +13.9 pts | ||
| Year to date | -33.0% | +12.3% | −45.3 pts | ||
| 1 year | +4.3% | +12.4% | −8.2 pts | ||
| 3 years | +81.8% | +78.8% | +3.0 pts | +22.0% | +21.4% |
| 5 years | +10.2% | +75.2% | −65.0 pts | +2.0% | +11.9% |
| 10 years | +784.3% | +311.1% | +473.2 pts | +24.4% | +15.2% |
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases KORU Medical Systems filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About KORU Medical Systems
Surgical & Medical Instruments & Apparatus
KORU Medical Systems develops, manufactures, and commercializes mechanical infusion devices designed for subcutaneous drug delivery. Its core product line, the FREEDOM Infusion System, features the FREEDOM60 and FreedomEdge syringe drivers, subcutaneous safety needle sets, and precision flow rate tubing. These systems administer subcutaneous medications such as immunoglobulin for primary immunodeficiency and chronic inflammatory demyelinating polyneuropathy, alongside treatments for conditions like generalized myasthenia gravis. The business operates across three primary streams: domestic core, international core, and biopharmaceutical services, which offers testing and engineering support for clinical trials. The company provides its products and services to pharmaceutical firms, home infusion providers, specialty pharmacies, and distributors.
Company profile, executives and historyKORU Medical Systems stock: common questions
What is KORU Medical Systems's stock price?
KRMD closed at $3.89 on Nov 11, 2026, up 23.10% on the day. Over the past 52 weeks it traded between $2.86 and $6.61.
What is KORU Medical Systems's market cap?
KORU Medical Systems was worth $179.61M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is KRMD's P/E ratio?
KORU Medical Systems lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does KORU Medical Systems make?
KORU Medical Systems reported revenue of $46.27M for the twelve months to Sep 30, 2026, up 18.4% from a year earlier.
Does KORU Medical Systems pay a dividend?
No. KORU Medical Systems has not paid a cash dividend over the last twelve months.
When does KORU Medical Systems report earnings next?
KORU Medical Systems is expected to report Q4 FY2026 results on Mar 11, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has KRMD stock performed over the past year?
Including dividends, KRMD returned +4.3% over the past year, against +12.4% for the S&P 500.
How many KRMD shares are sold short?
1M shares were sold short at the latest FINRA report, 2.26% of the float, or 6.5 days of average trading volume.
Who are KORU Medical Systems's competitors?
Companies most similar to KORU Medical Systems by business, industry and size include IRMD, MHUAF, UTMD, CLPT, CTSO.
See a number that looks wrong?